Privo Technologies, LLC secured a $1,170,285 NIH SBIR/STTR award: Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer)
Amount Raised
$1.17 Million
Round Type
Grant
PeabodyBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
RFA-CA-22-025 application entitled “Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer)” Project Summary: According to the American Cancer Society, about 54,000 people in the US will be newly diagnosed with oral cancer (OC) in 2022, causing 11,230 deaths. Historically, OC has been present in heavy smokers and drinkers, however OC has also become more prevalent in younger populations due to human
Who to call at Privo Technologies, and when
A new round usually means Privo Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Privo Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Privo Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Privo Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Privo Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Privo Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.